Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.

[1]  M. Prins,et al.  A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation. , 2006, Blood.

[2]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[3]  C. Carlson,et al.  Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women. , 2006, American journal of epidemiology.

[4]  John Danesh,et al.  Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls , 2006, The Lancet.

[5]  Suzanne Cheng,et al.  Matched Case-Control Study on Factor V Leiden and the Prothrombin G20210A Mutation in Patients With Ischemic Stroke/Transient Ischemic Attack Up to the Age of 60 Years , 2005, Stroke.

[6]  B. Nordestgaard,et al.  Phenotype of Heterozygotes for Low-Density Lipoprotein Receptor Mutations Identified in Different Background Populations , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[7]  B. Nordestgaard,et al.  Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. , 2004, Blood.

[8]  A. Hingorani,et al.  Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.

[9]  G. Caimi,et al.  Genetic risk factors in myocardial infarction at young age. , 2004, Minerva cardioangiologica.

[10]  B. Nordestgaard,et al.  Hemochromatosis mutations in the general population: iron overload progression rate. , 2004, Blood.

[11]  P. Schnohr,et al.  Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population , 2004, Annals of Internal Medicine.

[12]  M. Vasef,et al.  Detection of factor V leiden and prothrombin gene mutations in patients who died with thrombotic events. , 2009, Archives of pathology & laboratory medicine.

[13]  A. Folsom,et al.  Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism , 2002, American journal of hematology.

[14]  B. Nordestgaard,et al.  Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.

[15]  A. Tosetto,et al.  Phenotypic APC Resistance in Carriers of the A20210 Prothrombin Mutation Is Associated with an Increased Risk of Venous Thrombosis , 2001, Thrombosis and Haemostasis.

[16]  M. Margaglione,et al.  Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism , 2001, Thrombosis and Haemostasis.

[17]  P. Reitsma,et al.  Genetic risk factors for venous thrombosis. , 2000, Molecular genetics and metabolism.

[18]  P. Ridker,et al.  G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. , 1999, Circulation.

[19]  D. Steinberg,et al.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Cumming,et al.  The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population , 1997, British journal of haematology.

[21]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.